http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2021102883-A4
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_20692cbed521871d5e3721c33fe645d6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4484734847e9a1ba502670311a900825 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8ce45244098534969b0438fd1c465ae4 |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-435 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N21-251 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23C1-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23C9-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1709 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0095 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 |
classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N21-25 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23C1-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23C9-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
filingDate | 2021-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2021-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4fd852230916969863b04bf689708833 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_828a99df1e63b97f542dd3f8eb464624 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e83e26917c380bb53029eb4aab0863e |
publicationDate | 2021-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | AU-2021102883-A4 |
titleOfInvention | Design and evaluation of camel milk as a functional food for anti diabetic property |
abstract | DESIGN AND EVALUATION OF CAMEL MILK AS A FUNCTIONAL FOOD FOR nANTI DIABETIC PROPERTY nAbstract: nCamels have the tendency to yield more food and over longer amounts of time than most certain nspecies in extreme conditions and low feed demands, indicating their success as dairy products. nBreed, size, equality, season, diet, and management are the most significant factors influencing ncamel milk generation. Camel milk is usually translucent and dry, with a sweet and sharp flavour, nbut it may also have one salty flavour due to the plants that camels consume in the desert. Camel nmilk is well-known among nomads for its ability to treat a variety of diseases, particularly diabetes. nThe number of individuals living with type 2 diabetes has increased sharply in recent years, npushing health-care services beyond their limits. Throughout the Middle East, it is a common nbelief that drinking camel milk on a daily basis will help avoid and regulate diabetes. Camel milk nhas currently been confirmed to have such features. The following options are suggested from a nstudy of the literature: 1. Insulin from camel milk has unique features that make it easier to absorb ninto the bloodstream than other sourced insulin or induce proteolysis tolerance; 2. Insulin from the ncamel is embodied in nanoparticles like lipid vesicles, which enable it to travel via the stomach nand into the circulation; 3. camel milk contains anti-diabetic properties. This invention is intended nin the development and evaluation of functional food from the camel milk for its anti-diabetic nproperty. The design is capable of finding the amino acid content and correlating it with the human ninsulin sequence. This method must be able to formulate and evaluate the anti-diabetic property of ncamel milk and will supplement its usage in further development of functional food products from ncamel milk which could aid in controlling the diabetics in Human by insulin synthesis and nsecretion by the pancreatic p-cells. n1 |
priorityDate | 2021-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 256.